{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:13Z","timestamp":1787020633170,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Training Program of Innovation and Entrepreneurship for Undergraduates","award":["S202510631110"],"award-info":[{"award-number":["S202510631110"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100131"],"award-info":[{"award-number":["82100131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-MSX0136"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0136"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth project of science and technology research program of Chongqing Education Commission of China","award":["KJQN202500416"],"award-info":[{"award-number":["KJQN202500416"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08339-z","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:54:49Z","timestamp":1780124089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toosendanin suppresses acute myeloid leukemia by targeting DDX5\/c-Myc axis to inhibit protein synthesis"],"prefix":"10.1186","volume":"24","author":[{"given":"Xianchao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-9927","authenticated-orcid":false,"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"8339_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:502\u201326. https:\/\/doi.org\/10.1002\/ajh.26822.","journal-title":"Am J Hematol"},{"key":"8339_CR2","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.clnves.2025.100007","volume":"1","author":"S Hou","year":"2025","unstructured":"Hou S, Liu J, Zhu Y. Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Invest. 2025;1:100007. https:\/\/doi.org\/10.1016\/j.clnves.2025.100007.","journal-title":"Cell Invest"},{"key":"8339_CR3","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.clnves.2024.100001","volume":"1","author":"C Zeng","year":"2025","unstructured":"Zeng C. Advances in cancer treatment: The role of new technologies and research. Cell Invest. 2025;1:100001. https:\/\/doi.org\/10.1016\/j.clnves.2024.100001.","journal-title":"Cell Invest"},{"key":"8339_CR4","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.coph.2025.102526","volume":"82","author":"B Wang","year":"2025","unstructured":"Wang B, Reville PK, Abbas HA. Therapeutic Hurdles in Acute Myeloid Leukemia: Leukemic Stem Cells, Inflammation and Immune Dysfunction. Curr Opin Pharmacol. 2025;82:102526. https:\/\/doi.org\/10.1016\/j.coph.2025.102526.","journal-title":"Curr Opin Pharmacol"},{"key":"8339_CR5","doi-asserted-by":"publisher","first-page":"111044","DOI":"10.1016\/j.biopha.2020.111044","volume":"133","author":"K Wang","year":"2021","unstructured":"Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother. 2021;133:111044. https:\/\/doi.org\/10.1016\/j.biopha.2020.111044.","journal-title":"Biomed Pharmacother"},{"key":"8339_CR6","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.clnves.2025.100045","volume":"2","author":"J Chen","year":"2026","unstructured":"Chen J, Huang Q, Hou C, Liang J, Guan J, Chen S, et al. Lycium barbarum polysaccharide suppresses uridine induced malignant progression of lung adenocarcinoma via UPP1 regulation. Cell Invest. 2026;2:100045. https:\/\/doi.org\/10.1016\/j.clnves.2025.100045.","journal-title":"Cell Invest"},{"key":"8339_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.02.002","volume":"82","author":"Y-L Shi","year":"2007","unstructured":"Shi Y-L, Li M-F. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine. Prog Neurobiol. 2007;82:1\u201310. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.02.002.","journal-title":"Prog Neurobiol"},{"key":"8339_CR8","doi-asserted-by":"publisher","first-page":"eabq3558","DOI":"10.1126\/scitranslmed.abq3558","volume":"15","author":"F Yang","year":"2023","unstructured":"Yang F, Zhang D, Jiang H, Ye J, Zhang L, Bagley SJ, et al. Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy. Sci Transl Med. 2023;15:eabq3558. https:\/\/doi.org\/10.1126\/scitranslmed.abq3558.","journal-title":"Sci Transl Med"},{"key":"8339_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13046-023-02666-5","volume":"42","author":"X Jia","year":"2023","unstructured":"Jia X, Wang P, Huang C, Zhao D, Wu Q, Lu B, et al. Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth. J Exp Clin Canc Res. 2023;42:97. https:\/\/doi.org\/10.1186\/s13046-023-02666-5.","journal-title":"J Exp Clin Canc Res"},{"key":"8339_CR10","doi-asserted-by":"publisher","unstructured":"Yang T, Xu R, Huo J, Wang B, Du X, Dai B, et al. WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2\/Stat3 and Wnt\/\u03b2-catenin signaling. Cancer Lett. 2021;50\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2021.05.010.","DOI":"10.1016\/j.canlet.2021.05.010"},{"key":"8339_CR11","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1038\/onc.2017.270","volume":"36","author":"T Zhang","year":"2017","unstructured":"Zhang T, Li J, Yin F, Lin B, Wang Z, Xu J, et al. Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3. Oncogene. 2017;36:6627\u201339. https:\/\/doi.org\/10.1038\/onc.2017.270.","journal-title":"Oncogene"},{"key":"8339_CR12","doi-asserted-by":"publisher","first-page":"109739","DOI":"10.1016\/j.cbi.2021.109739","volume":"351","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yang F, Mei X, Yang R, Lu B, Wang Z, et al. Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy. Chemico-Biol Interact. 2022;351:109739. https:\/\/doi.org\/10.1016\/j.cbi.2021.109739.","journal-title":"Chemico-Biol Interact"},{"key":"8339_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1875-5364(24)60693-X","volume":"22","author":"S Li","year":"2024","unstructured":"Li S, Xiong Q, Shen Y, Lin J, Zhang L, Wu Y, et al. Toosendanin: upgrade of an old agent in cancer treatment. Chin J Nat Med. 2024;22:887\u201399. https:\/\/doi.org\/10.1016\/S1875-5364(24)60693-X.","journal-title":"Chin J Nat Med"},{"key":"8339_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.tiv.2012.09.013","volume":"27","author":"J Ju","year":"2013","unstructured":"Ju J, Qi Z, Cai X, Cao P, Liu N, Wang S, et al. Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells. Toxicol Vitro Pergamon. 2013;27:232\u20138. https:\/\/doi.org\/10.1016\/j.tiv.2012.09.013.","journal-title":"Toxicol Vitro Pergamon"},{"key":"8339_CR15","doi-asserted-by":"publisher","first-page":"e52536","DOI":"10.1371\/journal.pone.0052536","volume":"7","author":"J Ju","year":"2012","unstructured":"Ju J, Qi Z, Cai X, Cao P, Huang Y, Wang S et al. R <>Zhou editor 2012 The Apoptotic Effects of Toosendanin Are Partially Mediated by Activation of Deoxycytidine Kinase in HL-60 Cells. PLoS ONE 7 e52536 https:\/\/doi.org\/10.1371\/journal.pone.0052536.","journal-title":"PLoS ONE"},{"key":"8339_CR16","doi-asserted-by":"publisher","first-page":"e1519","DOI":"10.1002\/wrna.1519","volume":"10","author":"Z Xing","year":"2019","unstructured":"Xing Z, Ma WK, Tran EJ. The DDX5\/Dbp2 subfamily of DEAD-box RNA helicases. WIREs RNA. 2019;10:e1519. https:\/\/doi.org\/10.1002\/wrna.1519.","journal-title":"WIREs RNA"},{"key":"8339_CR17","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.celrep.2014.05.010","volume":"7","author":"E Dardenne","year":"2014","unstructured":"Dardenne E, Polay Espinoza M, Fattet L, Germann S, Lambert M-P, Neil H, et al. RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Rep. 2014;7:1900\u201313. https:\/\/doi.org\/10.1016\/j.celrep.2014.05.010.","journal-title":"Cell Rep"},{"key":"8339_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13045-018-0656-7","volume":"11","author":"M Zhang","year":"2018","unstructured":"Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan C, et al. The lncRNA NEAT1 activates Wnt\/\u03b2-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol. 2018;11:113. https:\/\/doi.org\/10.1186\/s13045-018-0656-7.","journal-title":"J Hematol Oncol"},{"key":"8339_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s13058-014-0496-5","volume":"16","author":"KKN Guturi","year":"2014","unstructured":"Guturi KKN, Sarkar M, Bhowmik A, Das N, Ghosh MK. DEAD-box protein p68 is regulated by \u03b2-catenin\/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression. Breast Cancer Res. 2014;16:496. https:\/\/doi.org\/10.1186\/s13058-014-0496-5.","journal-title":"Breast Cancer Res"},{"key":"8339_CR20","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1158\/0008-5472.CAN-08-0932","volume":"68","author":"EL Clark","year":"2008","unstructured":"Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, et al. The RNA helicase p68 is a novel Androgen Receptor Co-Activator involved in splicing and is over-expressed in Prostate Cancer. Cancer Res. 2008;68:7938\u201346. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0932.","journal-title":"Cancer Res"},{"key":"8339_CR21","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1038\/onc.2012.482","volume":"32","author":"S Lin","year":"2013","unstructured":"Lin S, Tian L, Shen H, Gu Y, Li J-L, Chen Z, et al. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia. Oncogene. 2013;32:4845\u201353. https:\/\/doi.org\/10.1038\/onc.2012.482.","journal-title":"Oncogene"},{"key":"8339_CR22","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.celrep.2014.05.019","volume":"7","author":"A Mazurek","year":"2014","unstructured":"Mazurek A, Park Y, Miething C, Wilkinson JE, Gillis J, Lowe SW, et al. Acquired Dependence of Acute Myeloid Leukemia on the DEAD-Box RNA Helicase DDX5. Cell Rep Elsevier BV. 2014;7:1887\u201399. https:\/\/doi.org\/10.1016\/j.celrep.2014.05.019.","journal-title":"Cell Rep Elsevier BV"},{"key":"8339_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-0716-0954-5_15","volume":"2213","author":"L Huang","year":"2021","unstructured":"Huang L, Wang D, Zhang C. Drug Affinity Responsive Target Stability (DARTS) Assay to Detect Interaction Between a Purified Protein and a Small Molecule. Methods Mol Biol Clifton N J. 2021;2213:175\u201382. https:\/\/doi.org\/10.1007\/978-1-0716-0954-5_15.","journal-title":"Methods Mol Biol Clifton N J"},{"key":"8339_CR24","doi-asserted-by":"publisher","first-page":"20453","DOI":"10.1073\/pnas.1909047116","volume":"116","author":"G Wu","year":"2019","unstructured":"Wu G, Xing Z, Tran EJ, Yang D. DDX5 helicase resolves G-quadruplex and is involved in MYC gene transcriptional activation. Proc Natl Acad Sci USA. 2019;116:20453\u201361. https:\/\/doi.org\/10.1073\/pnas.1909047116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8339_CR25","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.xpro.2022.101559","volume":"3","author":"J Lu","year":"2022","unstructured":"Lu J, Zhao H, Yang L, Jiang X. Protocol to establish a stable MLL-AF9_AML mouse model. STAR Protocols. 2022;3:101559. https:\/\/doi.org\/10.1016\/j.xpro.2022.101559.","journal-title":"STAR Protocols"},{"key":"8339_CR26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/cancers14051100","volume":"14","author":"S Kamran","year":"2022","unstructured":"Kamran S, Sinniah A, Abdulghani MAM, Alshawsh MA. Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review. Cancers (Basel). 2022;14:1100. https:\/\/doi.org\/10.3390\/cancers14051100.","journal-title":"Cancers (Basel)"},{"key":"8339_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"I Pellarin","year":"2025","unstructured":"Pellarin I, Dall\u2019Acqua A, Favero A, Segatto I, Rossi V, Crestan N, et al. Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther. 2025;10:11. https:\/\/doi.org\/10.1038\/s41392-024-02080-z.","journal-title":"Signal Transduct Target Ther"},{"key":"8339_CR28","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/ijms21061960","volume":"21","author":"L Ding","year":"2020","unstructured":"Ding L, Cao J, Lin W, Chen H, Xiong X, Ao H, et al. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. Int J Mol Sci. 2020;21:1960. https:\/\/doi.org\/10.3390\/ijms21061960.","journal-title":"Int J Mol Sci"},{"key":"8339_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.semcancer.2020.05.015","volume":"80","author":"C Braicu","year":"2022","unstructured":"Braicu C, Zanoaga O, Zimta A-A, Tigu AB, Kilpatrick KL, Bishayee A, et al. Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells. Semin Cancer Biol. 2022;80:218\u201336. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.015.","journal-title":"Semin Cancer Biol"},{"key":"8339_CR30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","volume":"57","author":"SH Dho","year":"2025","unstructured":"Dho SH, Cho M, Woo W, Jeong S, Kim LK. Caspases as master regulators of programmed cell death: apoptosis, pyroptosis and beyond. Exp Mol Med Nat Publishing Group. 2025;57:1121\u201332. https:\/\/doi.org\/10.1038\/s12276-025-01470-9.","journal-title":"Exp Mol Med Nat Publishing Group"},{"key":"8339_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1478-811X-8-31","volume":"8","author":"GV Chaitanya","year":"2010","unstructured":"Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8:31. https:\/\/doi.org\/10.1186\/1478-811X-8-31.","journal-title":"Cell Commun Signal"},{"key":"8339_CR32","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.gendis.2022.02.008","volume":"10","author":"S Tabassum","year":"2023","unstructured":"Tabassum S, Ghosh MK. DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer. Genes Dis. 2023;10:1220\u201341. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.008.","journal-title":"Genes Dis"},{"key":"8339_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13046-023-02787-x","volume":"42","author":"F Li","year":"2023","unstructured":"Li F, Ling X, Chakraborty S, Fountzilas C, Wang J, Jamroze A, et al. Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. J Exp Clin Cancer Res. 2023;42:213. https:\/\/doi.org\/10.1186\/s13046-023-02787-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"8339_CR34","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundb\u00e4ck T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc Nat Publishing Group. 2014;9:2100\u201322. https:\/\/doi.org\/10.1038\/nprot.2014.138.","journal-title":"Nat Protoc Nat Publishing Group"},{"key":"8339_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bpj.2010.12.3699","volume":"100","author":"M Held","year":"2011","unstructured":"Held M, Metzner P, Prinz J-H, No\u00e9 F. Mechanisms of protein-ligand association and its modulation by protein mutations. Biophys J. 2011;100:701\u201310. https:\/\/doi.org\/10.1016\/j.bpj.2010.12.3699.","journal-title":"Biophys J"},{"key":"8339_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Volume 341. New York, N.Y.: Science; 2013. pp. 84\u20137. https:\/\/doi.org\/10.1126\/science.1233606."},{"key":"8339_CR37","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1016\/j.molcel.2021.09.015","volume":"81","author":"J Li","year":"2021","unstructured":"Li J, Cai Z, Vaites LP, Shen N, Mitchell DC, Huttlin EL, et al. Proteome-wide mapping of short-lived proteins in human cells. Mol Cell. 2021;81:4722\u2013e47355. https:\/\/doi.org\/10.1016\/j.molcel.2021.09.015.","journal-title":"Mol Cell"},{"key":"8339_CR38","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.15252\/emmm.201607315","volume":"9","author":"K Harhouri","year":"2017","unstructured":"Harhouri K, Navarro C, Depetris D, Mattei M-G, Nissan X, Cau P, et al. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation. EMBO Mol Med. 2017;9:1294\u2013313. https:\/\/doi.org\/10.15252\/emmm.201607315.","journal-title":"EMBO Mol Med"},{"key":"8339_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema K-J, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435\u201355. https:\/\/doi.org\/10.1080\/15548627.2018.1474314.","journal-title":"Autophagy"},{"key":"8339_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.14348\/molcells.2017.0115","volume":"40","author":"CH Ji","year":"2017","unstructured":"Ji CH, Kwon YT. Crosstalk and Interplay between the Ubiquitin-Proteasome System and Autophagy. Mol Cells. 2017;40:441\u20139. https:\/\/doi.org\/10.14348\/molcells.2017.0115.","journal-title":"Mol Cells"},{"key":"8339_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc2819","volume":"10","author":"J Van Riggelen","year":"2010","unstructured":"Van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010;10:301\u20139. https:\/\/doi.org\/10.1038\/nrc2819.","journal-title":"Nat Rev Cancer"},{"key":"8339_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/onc.2013.561","volume":"34","author":"K Tago","year":"2015","unstructured":"Tago K, Funakoshi-Tago M, Itoh H, Furukawa Y, Kikuchi J, Kato T, et al. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5. Oncogene Nat Publishing Group. 2015;34:314\u201322. https:\/\/doi.org\/10.1038\/onc.2013.561.","journal-title":"Oncogene Nat Publishing Group"},{"key":"8339_CR43","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood-2016-10-691428","volume":"129","author":"TA Milne","year":"2017","unstructured":"Milne TA. Mouse models of MLL leukemia: recapitulating the human disease. Blood. 2017;129:2217\u201323. https:\/\/doi.org\/10.1182\/blood-2016-10-691428.","journal-title":"Blood"},{"key":"8339_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-018-0024-8","author":"Y Jin","year":"2019","unstructured":"Jin Y. Quercetin attenuates toosendanin-induced hepatotoxicity through inducing the Nrf2\/GCL\/GSH antioxidant signaling pathway. Acta Pharmacol Sin. 2019. https:\/\/doi.org\/10.1038\/s41401-018-0024-8.","journal-title":"Acta Pharmacol Sin"},{"key":"8339_CR45","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.3390\/ijms17111928","volume":"17","author":"L Cao","year":"2016","unstructured":"Cao L, Qu D, Wang H, Zhang S, Jia C, Shi Z, et al. Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor \u03b2- and p53-Mediated Apoptosis. Int J Mol Sci. 2016;17:1928. https:\/\/doi.org\/10.3390\/ijms17111928.","journal-title":"Int J Mol Sci"},{"key":"8339_CR46","doi-asserted-by":"publisher","first-page":"1662619","DOI":"10.3389\/fcell.2025.1662619","volume":"13","author":"V Bianconi","year":"2025","unstructured":"Bianconi V, Mozzetta C. Unwinding new therapeutic opportunities in rhabdomyosarcoma: the role of RNA helicase DDX5. Front Cell Dev Biol. 2025;13:1662619. https:\/\/doi.org\/10.3389\/fcell.2025.1662619.","journal-title":"Front Cell Dev Biol"},{"key":"8339_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13046-014-0064-y","volume":"33","author":"T-Y Dai","year":"2014","unstructured":"Dai T-Y, Cao L, Yang Z-C, Li Y-S, Tan L, Ran X-Z, et al. P68 RNA helicase as a molecular target for cancer therapy. J Experimental Clin Cancer Research: CR. 2014;33:64. https:\/\/doi.org\/10.1186\/s13046-014-0064-y.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"8339_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber SL. The Rise of Molecular Glues. Cell. 2021;184:3\u20139. https:\/\/doi.org\/10.1016\/j.cell.2020.12.020.","journal-title":"Cell"},{"key":"8339_CR49","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc.2017.36","volume":"17","author":"CV Dang","year":"2017","unstructured":"Dang CV, Reddy EP, Shokat KM, Soucek L. Drugging the undruggable cancer targets. Nat Rev Cancer. 2017;17:502\u20138. https:\/\/doi.org\/10.1038\/nrc.2017.36.","journal-title":"Nat Rev Cancer"},{"key":"8339_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the Path to Cancer. Cell. 2012;149:22\u201335. https:\/\/doi.org\/10.1016\/j.cell.2012.03.003.","journal-title":"Cell"},{"key":"8339_CR51","doi-asserted-by":"publisher","first-page":"eadv7648","DOI":"10.1126\/sciadv.adv7648","volume":"11","author":"W Li","year":"2025","unstructured":"Li W, Zhao Y, Wu D, Chen Z, Qing Y, Yang F, et al. FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia. Sci Adv. 2025;11:eadv7648. https:\/\/doi.org\/10.1126\/sciadv.adv7648.","journal-title":"Sci Adv"},{"key":"8339_CR52","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","volume":"129","author":"N Hein","year":"2017","unstructured":"Hein N, Cameron DP, Hannan KM, Nguyen N-YN, Fong CY, Sornkom J, et al. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood. 2017;129:2882\u201395. https:\/\/doi.org\/10.1182\/blood-2016-05-718171.","journal-title":"Blood"},{"key":"8339_CR53","doi-asserted-by":"publisher","first-page":"e881","DOI":"10.1002\/ctm2.881","volume":"12","author":"X Ling","year":"2022","unstructured":"Ling X, Wu W, Aljahdali IAM, Liao J, Santha S, Fountzilas C, et al. FL118, acting as a \u2018molecular glue degrader\u2019, binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy. Clin Transl Med. 2022;12:e881. https:\/\/doi.org\/10.1002\/ctm2.881.","journal-title":"Clin Transl Med"},{"key":"8339_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11060-006-9172-7","volume":"80","author":"P Zhang","year":"2006","unstructured":"Zhang P, Li H, Wu M-L, Chen X-Y, Kong Q-Y, Wang X-W, et al. c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J Neurooncol. 2006;80:123\u201331. https:\/\/doi.org\/10.1007\/s11060-006-9172-7.","journal-title":"J Neurooncol"},{"key":"8339_CR55","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/onc.2008.312","volume":"27","author":"B Hoffman","year":"2008","unstructured":"Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene. 2008;27:6462\u201372. https:\/\/doi.org\/10.1038\/onc.2008.312.","journal-title":"Oncogene"},{"key":"8339_CR56","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1038\/s41467-022-32368-z","volume":"13","author":"J Edwards-Hicks","year":"2022","unstructured":"Edwards-Hicks J, Su H, Mangolini M, Yoneten KK, Wills J, Rodriguez-Blanco G, et al. MYC sensitises cells to apoptosis by driving energetic demand. Nat Commun. 2022;13:4674. https:\/\/doi.org\/10.1038\/s41467-022-32368-z.","journal-title":"Nat Commun"},{"key":"8339_CR57","doi-asserted-by":"publisher","first-page":"a014407","DOI":"10.1101\/cshperspect.a014407","volume":"4","author":"SB McMahon","year":"2014","unstructured":"McMahon SB. MYC and the Control of Apoptosis. Cold Spring Harb Perspect Med. 2014;4:a014407. https:\/\/doi.org\/10.1101\/cshperspect.a014407.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"8339_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S M\u00e9ndez-Ferrer","year":"2020","unstructured":"M\u00e9ndez-Ferrer S, Bonnet D, Steensma DP, Hasserjian RP, Ghobrial IM, Gribben JG, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020;20:285\u201398. https:\/\/doi.org\/10.1038\/s41568-020-0245-2.","journal-title":"Nat Rev Cancer"},{"key":"8339_CR59","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41419-025-07980-8","volume":"16","author":"M Dian","year":"2025","unstructured":"Dian M, Yun L, Meng Q, Lin S, Ji M, Zhou Y, et al. Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis. Cell Death Dis. 2025;16:660. https:\/\/doi.org\/10.1038\/s41419-025-07980-8.","journal-title":"Cell Death Dis"},{"key":"8339_CR60","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1158\/0008-5472.CAN-23-2729","volume":"83","author":"S Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay S, Huang H-Y, Lin Z, Ranieri M, Li S, Sahu S, et al. Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy. Cancer Res. 2023;83:4095\u2013111. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2729.","journal-title":"Cancer Res"},{"key":"8339_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.20517\/cdr.2022.127","volume":"6","author":"S Mart\u00ednez-Mart\u00edn","year":"2023","unstructured":"Mart\u00ednez-Mart\u00edn S, Beaulieu M-E, Soucek L. Targeting MYC-driven lymphoma: lessons learned and future directions. Cancer Drug Resist Alhambra Calif. 2023;6:205\u201322. https:\/\/doi.org\/10.20517\/cdr.2022.127.","journal-title":"Cancer Drug Resist Alhambra Calif"},{"key":"8339_CR62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.7150\/ijbs.51458","volume":"17","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhu C, Tang L, Chen Q, Guan N, Xu K, et al. MYC dysfunction modulates stemness and tumorigenesis in breast cancer. Int J Biol Sci. 2021;17:178\u201387. https:\/\/doi.org\/10.7150\/ijbs.51458.","journal-title":"Int J Biol Sci"},{"key":"8339_CR63","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.critrevonc.2025.104786","volume":"213","author":"P Dai","year":"2025","unstructured":"Dai P, Wang L. Targeting c-MYC has a key role in hepatocellular carcinoma therapy. Crit Rev Oncol Hematol. 2025;213:104786. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104786.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8339_CR64","doi-asserted-by":"publisher","first-page":"156586","DOI":"10.1016\/j.phymed.2025.156586","volume":"140","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zhang J, Gao X, Wu Z, Yang L, Tian K, et al. Toosendanin-induced liver damage through irreparable DNA damage and autophagy flow blockade. Phytomedicine. 2025;140:156586. https:\/\/doi.org\/10.1016\/j.phymed.2025.156586.","journal-title":"Phytomedicine"},{"key":"8339_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022;21:181\u2013200. https:\/\/doi.org\/10.1038\/s41573-021-00371-6.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08339-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:11:10Z","timestamp":1783437070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08339-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8339"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08339-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Chongqing Medical University (Approval No. 2025-361-01). Informed consent was obtained from all individuals included in the study. All animal experiments were approved by the Institutional Animal Care and Use Committee of Chongqing Medical University (Approval No. IACUC-CQMU-2023-12096).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"862"}}